Chem. J. Chinese Universities ›› 2017, Vol. 38 ›› Issue (10): 1764.doi: 10.7503/cjcu20170239

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Bioactivities Evaluation of Novel 1-(1,3,5-Triazin-6-yl)-3-methyl-4-(5-phenyl-1,3,4-oxadiazol-2-yl) pyrazole

ZHANG Chenglu*(), SUN Xiaona, LI Chuanyin, CAI Jiying, WANG Jing, LI Yizheng, WANG Huayu   

  1. College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China
  • Received:2017-04-19 Online:2017-10-10 Published:2017-09-08
  • Contact: ZHANG Chenglu E-mail:zhangchenglu@lnnu.edu.cn
  • Supported by:
    † Supported by the Science and Technology Research Program of Liaoning Provincial Department of Education, China(No.2009A426).

Abstract:

Eighteen novel multi-heterocyclic molecules[7A(a—f), 7B(a—f), 7C(a—f)] were designed and synthesized by hybrid-linking 1,3,4-oxadiazole and 1,3,5-triazine onto pyrazole. The structures of all the compounds were confirmed by IR, NMR and HRMS. The inhibitory activities of target molecules against protein tyrosine phosphatase 1B(PTP1B) and cell division cycle 25 phosphatase B(Cdc25B) were evaluated. As a result, all of the target molecules behave good inhibitory activities against PTP1B and Cdc25B, in which nine compounds show excellent inhibitory activities, respectively. The inhibitory activities of nine compounds are better than the reference oleanolic acid and Na3VO4, respectively. The nine compounds are expected to become potential inhibitors of PTP1B and Cdc25B.

Key words: Pyrazole, 1,3,4-Oxadiazole, 1,3,5-Triazine, PTP1B inhibitor, Cdc25B inhibitor

CLC Number: 

TrendMD: